In the notice letter, Lupin alleges that all 10 patents associated with Ranexa are invalid, unenforceable and/or will not be infringed by Lupin’s manufacture, use or sale of
ViroStatics claimed that AV-HALTS are a new class of drugs that combine direct anti-viral activity with a reduction in the chronically elevated immune system activation that is now
Repros is expected to be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both
Mr Wieland has over 30 years of senior financial experience with US-based public and private companies. He has served as the CFO of four NASDAQ-listed companies within the
The expanded agreement solidifies Patheon as a preferred supplier to Merck. Patheon’s projects and services are expected to be delivered to Merck from eight of its global facilities.
As per the terms of the transaction, GSK is expected to gain full ownership of Phoenix in a move to accelerate sales growth and further extend its pharmaceutical
Jiangbo Pharma expects to complete the pilot production requirements and receive final distribution approval from SFDA in July 2010. Jiangbo Pharma plans to commence commercial distribution immediately following
Zolmitriptan is currently commercially available for the treatment of migraine headaches in adults, and faces initial patent expirations in 2013. MonoSol Rx, along with APR and its partner
Valacyclovir Hydrochloride tablets are a nucleoside analogue DNA polymerase inhibitor indicated for use in adult patients for cold sores (Herpes Labialis), genital herpes and herpes zoster. The efficacy
Breckenridge Pharma is a pharmaceutical marketing, research and development company founded in 1983 that markets a range of generic prescription products in many therapeutic categories including several ValuBrand
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.